EDESA BIOTECH
Edesa Biotech is a clinical-stage private company focused on developing treatments for dermatological and anorectal diseases. The initial focus is on developing novel, safe and potent alternatives to steroids for Allergic Contact Dermatitis, Hemorrhoids, and Anal Fissures. Edesa Biotech’s lead asset, EB01 is a novel non-steroidal anti-inflammatory molecule for the treatment of allergic contact dermatitis which has already demonstrated statistically significant improvements in multiple clinical studies.
EDESA BIOTECH
Industry:
Biotechnology Life Science
Founded:
2015-01-01
Address:
Markham, Ontario, Canada
Country:
Canada
Website Url:
http://www.edesabiotech.com
Total Employee:
1+
Status:
Active
Contact:
(905)-475 1234
Email Addresses:
[email protected]
Total Funding:
42.31 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-06-07 | Stellar Biotechnologies | Stellar Biotechnologies acquired by Edesa Biotech | N/A |
Investors List
Strategic Innovation Fund (SIF)
Strategic Innovation Fund (SIF) investment in Grant - Edesa Biotech
Lumira Ventures
Lumira Ventures investment in Series A - Edesa Biotech
Inveready
Inveready investment in Series A - Edesa Biotech
Pharmascience
Pharmascience investment in Series A - Edesa Biotech
Official Site Inspections
http://www.edesabiotech.com Semrush global rank: 1.31 M Semrush visits lastest month: 22.35 K
- Host name: 155.26.180.107.host.secureserver.net
- IP address: 107.180.26.155
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Edesa Biotech"
Edesa Biotech, Inc. (Nasdaq: EDSA) – Clinical Stage …
Edesa Biotech, Inc.. We are a clinical-stage biopharmaceutical company exploring new ways to treat inflammatory and immune-related diseases.See details»
Corporate Presentation - edesabiotech.com
Organization (North America) Synergies with pipelines/interests of potential strategic partners . $4.7B. $5.2B. $3.9B $3.7B. Medical Dermatology. Respiratory; EB06 - Vitiligo. First-in-Class …See details»
Edesa Biotech - Crunchbase Company Profile & Funding
Edesa Biotech is a clinical-stage private company focused on developing treatments for dermatological and anorectal diseases. The initial focus is on …See details»
Edesa Biotech (EDSA) Company Profile & Description - Stock …
Apr 17, 2025 Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products …See details»
Edesa Biotech, Inc. | LinkedIn
Edesa Biotech, Inc. (Nasdaq: EDSA) is a clinical-stage biopharmaceutical company developing innovative ways to treat inflammatory and immune-related diseases.See details»
Edesa Biotech, Inc - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Edesa Biotech, Inc of Markham, ON. Get the latest business insights from Dun & Bradstreet.See details»
Edesa Biotech, Inc. - AnnualReports.com
Edesa Biotech, Inc. (Nasdaq: EDSA) is a clinical-stage biopharmaceutical company developing innovative ways to treat inflammatory and immune-related diseases.See details»
Edesa Biotech to Participate in Bloom Burton Healthcare
1 day ago [email protected]. Tags EDSA Conference Vitiligo. Recommended Reading. April 04, 2025 16:15 ET | Source: Edesa Biotech, Inc. Edesa Biotech Announces …See details»
Edesa Biotech CEO and Key Executive Team | Craft.co
Edesa Biotech's Chief Executive Officer, Director is Par Nijhawan. Other executives include Sean MacDonald, Chairman; Blair Gordon, Vice President, Research and Development and 4 …See details»
Governance | Edesa Biotech, Inc. (Nasdaq: EDSA)
In 2014, he founded Exzell Pharma, a specialty Canadian-based pharmaceutical organization that markets and commercializes approved products. He sold Exzell Pharma to BioLab Pharma in …See details»
Edesa Biotech Inc Company Profile - Overview - GlobalData
Website www.edesabiotech.com Telephone 1 905 4751234. No of Employees 16. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange EDSA (NASD) EPS XYZ. Net …See details»
Canada to invest $23 million in Ontario-based Edesa Biotech, Inc.
Oct 12, 2023 Canada’s Biomanufacturing and Life Sciences Strategy presents a long‑term vision to protect Canadians against future pandemics and other health emergencies and to grow an …See details»
Edesa Biotech 2025 Company Profile: Stock Performance
Edesa Biotech General Information Description. Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways …See details»
Edesa Biotech - Overview, News & Similar companies - ZoomInfo
Edesa Biotech contact info: Phone number: (289) 800-9600 Website: www.edesabiotech.com What does Edesa Biotech do? Edesa Biotech is a clinical-stage biopharmaceutical company …See details»
Edesa Biotech’s Founder Makes Strategic Investment in the …
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics …See details»
Edesa Biotech - Craft
Oct 29, 2024 Edesa Biotech is a company developing treatments for dermatological and gastrointestinal diseases. Its main product is EB01, a non-steroidal anti-inflammatory molecule …See details»
Edesa Biotech to Present at 2024 Bloom Burton & Co. Healthcare …
1 day ago Edesa Biotech will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference on May 5, 2025. Quiver AI Summary. Edesa Biotech, Inc., a clinical-stage …See details»
Leadership | Edesa Biotech, Inc. (Nasdaq: EDSA)
During his career, Koppenjan has received multiple advertising and public relations awards for product introduction campaigns and stakeholder outreach. He is a past member of the …See details»
Edesa Biotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Attendees interested in meeting with management can request meetings through the conference organizers or by contacting Edesa directly at [email protected]. About Edesa …See details»
Contact Us | Edesa Biotech, Inc. (Nasdaq: EDSA)
Headquarters. Our executive offices are located in the Greater Toronto Area Edesa Biotech, Inc. 100 Spy Court Markham, Ontario L3R 5H6 +1 289.800.9600See details»